People · Operator

ANNE G. ARCHIBALD

Named in public records as an officer, director or promoter · active 2018–2018 · Other Technology

1
Companies
1
Filings
$26.3M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
iraLogix, Inc.Other TechnologySeries A$26.3M$184.0M2018
Operator network

ANNE G. ARCHIBALD at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

James Smith · 20 companies · 1 sharedJames SmithMichael Dowdle · 4 companies · 1 sharedMichael DowdleDavid Bernard · 2 companies · 1 sharedDavid BernardMICHAEL B. DOWDLE · 2 companies · 1 sharedMICHAEL B. DOWDLERYAN WEBER · 2 companies · 1 sharedRYAN WEBERThomas G. Anderson · 2 companies · 1 sharedThomas G. AndersonANNE B. ARCHIBALD · 1 companies · 1 sharedANNE B. ARCHIBALDANNE M. ARCHIBALD · 1 companies · 1 sharedANNE M. ARCHIBALDJAMES M. HALUSZCZAK · 1 companies · 1 sharedJAMES M. HALUSZCZ…JOHN G. ARANOWICZ · 1 companies · 1 sharedJOHN G. ARANOWICZJoseph Hipsky · 1 companies · 1 sharedJoseph HipskyPAMELA S. O'ROURKE · 1 companies · 1 sharedPAMELA S. O'ROURKEPeter DeSilva · 1 companies · 1 sharedPeter DeSilvaRYAN M. WEBER · 1 companies · 1 sharedRYAN M. WEBERiraLogix, Inc. · $26.3M raisediraLogix, Inc.ANNE G. ARCHIBALDAA
ANNE G. ARCHIBALD Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside ANNE G. ARCHIBALD on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
James Smith120
Michael Dowdle14
David Bernard12
RYAN WEBER12
Thomas G. Anderson12
MICHAEL B. DOWDLE12
ANNE B. ARCHIBALD11
Peter DeSilva11
PAMELA S. O'ROURKE11
RYAN M. WEBER11
JAMES M. HALUSZCZAK11
ANNE M. ARCHIBALD11
JOHN G. ARANOWICZ11
Joseph Hipsky11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.